The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes with alpelisib (ALP) plus fulvestrant (FUL) after prior treatment (tx) with FUL in patients (pts) with advanced breast cancer (ABC): A real-world (RW) analysis.
 
Joyce O'Shaughnessy
Honoraria - Abbvie; Agendia; Amgen; Aptitude Health; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Clovis Oncology; Daiichi Sankyo; Eisai; G1 Therapeutics; Genentech; Gilead Sciences; GRAIL; Halozyme; HERON; Immunomedics; Ipsen; Lilly; Merck; Myriad Pharmaceuticals; Nektar; Novartis; Pfizer; Pharmacyclics; Pierre Fabre; Prime Oncology; Puma Biotechnology; Roche; Samsung; Sanofi; Seagen; Syndax; Synthon; Taiho Oncology; Takeda
Consulting or Advisory Role - Abbvie; Agendia; Amgen; Aptitude Health; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Clovis Oncology; Daiichi Sankyo; Eisai; G1 Therapeutics; Genentech; Gilead Sciences; GRAIL; Halozyme; HERON; Immunomedics; Ipsen; Lilly; Merck; Myriad Pharmaceuticals; Nektar; Novartis; Pfizer; Pharmacyclics; Pierre Fabre; Prime Oncology; Puma Biotechnology; Roche; Samsung; Sanofi; Seagen; Syndax; Synthon; Taiho Oncology; Takeda
Speakers' Bureau - AstraZeneca; Lilly; Novartis; Pfizer
Research Funding - Seagen (Inst)
Travel, Accommodations, Expenses - Abbvie; Agendia; Amgen; AstraZeneca; Celgene; Eisai; GRAIL; Ipsen; Lilly; Myriad Pharmaceuticals; Novartis; Pfizer; Puma Biotechnology; Roche; Sanofi; Seagen
 
Achim Woeckel
Consulting or Advisory Role - AstraZeneca; Celgene; Eisai; Lilly; MSD; Novartis; Pfizer; Roche
 
Barbara Pistilli
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/UCB Japan; Myriad Genetics; Novartis; PIERRE FABRE; Puma Biotechnology
Research Funding - DAIICHI-SANKYO (Inst); Merus (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Travel, Accommodations, Expenses - AstraZeneca; MSD Oncology; Novartis; Pfizer; Pierre Fabre
 
Roberto Hegg
No Relationships to Disclose
 
Linda T. Vahdat
Honoraria - Osmol Therapeutics; polyphor; Seagen
Consulting or Advisory Role - Berg Pharma; Depymed
Research Funding - Genentech/Roche (Inst); Immunomedics (Inst); Polyphor (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - we have a patent pending on the application for BMD progenitor cells (Inst)
 
Dragica Vuina
Employment - Novartis
 
Parisa(Fatemeh) Asad ZVK
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Timothy W Smith
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Julia Kim
Consulting or Advisory Role - Novartis
 
Ian Krop
Other Relationship - AstraZeneca; Context Therapeutics; Daiichi Sankyo; Genentech/Roche; MacroGenics; Novartis; Pfizer; Seagen
(OPTIONAL) Uncompensated Relationships - Novartis